IN THIS issue of the ARCHIVES, Burden et al1 compare the risk factors and the prognosis in a large sample of patients with multiple melanomas and in controls with a single melanoma. They also test the hypothesis of a possible link between CDKN2A mutations and the multiplicity of melanomas in the same patient.
Patients with multiple primary melanoma (MPM) are the individuals who have already developed successively or concomitantly several primary melanomas. This definition needs, however, several comments. Multiple melanoma should be distinguished from melanoma with metastases and melanoma with atypical nevi. This statement may appear useless, but the differential diagnosis is probably more confusing than expected. First, there is no reliable criterion to separate MPMs from a melanoma with an epidermotropic metastasis.2 Second, the differential diagnosis between benign melanocytic lesions and melanomas is probably a source of bias for the inclusion in multiple melanoma series. After a melanoma diagnosis, patients are more closely followed up, and nevi more frequently removed than in the general population. Physicians probably tend to lower their threshold for positive melanoma diagnosis when there is a histological doubt, since there is no new negative consequence for a patient who is already under surveillance. Therefore, one can suspect that there are more false-positive diagnoses of melanoma and more in situ melanoma diagnoses in patients who have already developed a melanoma than in other individuals. Whether in situ melanomas are true melanomas is still debated; their prognosis if not removed is unknown, but some of them are probably not true cancers. False diagnosis of multiple melanoma is probably even higher in concomitant melanoma. The fact that 2 primary melanomas are detected at the same time suggests that at least one of them has grown slowly enough to be detected only when the other one develops. This probably increases the risk that the slowly growing one is not a true melanoma. A multiple melanoma population is thus probably biased by patients with a single melanoma associated with skin metastases or with a benign melanocytic lesion (atypical nevi), or else with uncertainly malignant lesions (melanoma in situ).
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Purchase Online Access to this article for 24 hours
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Thank you for submitting a comment on this article. It will be reviewed by JAMA Dermatology editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 3
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Users' Guides to the Medical Literature
The Rational Clinical Examination
Make the Diagnosis: Melanoma
All results at
and access these and other features:
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.